BacterOMIC
BacterOMIC is dedicated to revolutionizing antibiotic therapy through advanced diagnostic systems that enable rapid and comprehensive susceptibility testing. Their mission is to combat antimicrobial resistance by providing precise diagnostics that guide effective treatment, ensuring better health outcomes worldwide. Their vision is a world where every patient receives optimal and affordable treatment thanks to faster and more accurate susceptibility tests.
Industries
Nr. of Employees
small (1-50)
BacterOMIC
ul. Ogrodowa 58, 00-876 Warszawa, IX piętro
Patents
Incubation well with an unvented gas cavity for use in a microfluidic chip
US-12290807-B2
View Details
Incubation well with an unvented gas cavity for use in a microfluidic chip
US-12290807-B2
View DetailsProducts
High-throughput antimicrobial susceptibility testing system
An integrated diagnostic platform for rapid, phenotypic antimicrobial susceptibility testing that supports hundreds of parallel bacterial cultures per test, direct testing from positive blood cultures, antibiotic synergy assessment, and customizable test panels.
High-throughput antimicrobial susceptibility testing system
An integrated diagnostic platform for rapid, phenotypic antimicrobial susceptibility testing that supports hundreds of parallel bacterial cultures per test, direct testing from positive blood cultures, antibiotic synergy assessment, and customizable test panels.
Services
Design of tailored antimicrobial test panels and support for integrating panels into laboratory workflows; applicable to human and veterinary pathogens.
Execution and support of comparative studies against reference methods to demonstrate analytical and clinical performance prior to market introduction.
Preparation and participation in regulatory interactions such as pre-submission engagements to support device certification pathways.
Workshops, conference presentations, and educational initiatives to increase awareness of antimicrobial resistance and diagnostic best practices.
Design of tailored antimicrobial test panels and support for integrating panels into laboratory workflows; applicable to human and veterinary pathogens.
Execution and support of comparative studies against reference methods to demonstrate analytical and clinical performance prior to market introduction.
Preparation and participation in regulatory interactions such as pre-submission engagements to support device certification pathways.
Workshops, conference presentations, and educational initiatives to increase awareness of antimicrobial resistance and diagnostic best practices.
Expertise Areas
- Antimicrobial susceptibility testing (AST)
- Rapid phenotypic diagnostic development
- Microfluidic device engineering
- Diagnostic validation and comparative studies
Key Technologies
- Phenotypic AST
- Microfluidics
- High-throughput miniaturized culture arrays
- Direct-from-blood diagnostic methods
News & Updates
BacterOMIC will participate in the Infection Prevention and Control (IPC) conference in Birmingham, featuring a presentation by Stephen Kidd on the evaluation of the BACTEROMIC AST System.
BacterOMIC will host lectures and workshops at the AdvMicro 2025 conference, with key topics on global healthcare challenges and innovative technology in microbiology.
Results from the Early Access Program (EAP) confirm the readiness of the BACTEROMIC system for market deployment.
BacterOMIC shares progress and activities in their educational mission to raise awareness about antimicrobial resistance.
An article highlighting the importance of education in saving lives and supporting antimicrobial resistance initiatives.
International patent protection obtained for innovative microfluidic chip and incubation segment technologies.
BacterOMIC will participate in the Infection Prevention and Control (IPC) conference in Birmingham, featuring a presentation by Stephen Kidd on the evaluation of the BACTEROMIC AST System.
BacterOMIC will host lectures and workshops at the AdvMicro 2025 conference, with key topics on global healthcare challenges and innovative technology in microbiology.
Results from the Early Access Program (EAP) confirm the readiness of the BACTEROMIC system for market deployment.
BacterOMIC shares progress and activities in their educational mission to raise awareness about antimicrobial resistance.
An article highlighting the importance of education in saving lives and supporting antimicrobial resistance initiatives.
International patent protection obtained for innovative microfluidic chip and incubation segment technologies.